Polaris Market Research presents its latest market research report, titled U.S. C-Reactive Protein Testing Market Demand, Growth Opportunity, 2025-2034. It is a comprehensive market research report analyzing the fast-evolving U.S. C-reactive protein testing market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, and industry developments. By going through the report, stakeholders can get an in-depth overview of the U.S. C-reactive protein testing market and its outlook during the forecast period.

U.S. C-Reactive Protein Testing Market Key Takeaways

• The U.S. C-reactive protein testing market size was valued at USD 769.66 million in 2024.
• The market is estimated to reach USD 1,253.69 million by 2034.
• The market is projected to witness a CAGR of 5.02% from 2025 to 2034.
• The immuno-turbidimetric assay segment held a major share of the market in 2024.
• The hs (high sensitivity) CRP segment is likely to grow at a robust pace during the forecast period.
• The hospitals segment held the largest share of end use in 2024.
• The home care settings segment is expected to grow at a robust pace from 2025 to 2034.

What is U.S. C-Reactive Protein Testing Market?

C-reactive protein (CRP) testing is a blood test that measures the level of CRP, a substance produced by the liver in response to inflammation. High CRP levels may signal infections, autoimmune conditions, or chronic diseases such as cardiovascular disorders. Physicians use this test to detect inflammation, monitor treatment effectiveness, and assess heart disease risk, making it a fast, reliable tool for diagnosing underlying health issues and guiding medical decisions.

Market Dynamics

The report examines the key market dynamics influencing the growth and development of the U.S. C-reactive protein testing market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.

Key Market Driver: Rising Healthcare Spending

Growing U.S. healthcare expenditure is enabling hospitals, clinics, and laboratories to invest in advanced diagnostic technologies and expand CRP testing capabilities. Higher spending improves patient access to preventive care and early disease detection, while encouraging both government and private providers to strengthen diagnostic infrastructure, which in turn supports wider availability and adoption of CRP testing services nationwide.

Market Opportunity: Growing Demand for Precision Medicine

Precision medicine relies on accurate biomarkers to guide therapy decisions, and CRP testing gives physicians critical insight into inflammation and disease activity that can be used to tailor treatments to individual patients. Oncologists, cardiologists, and rheumatologists are increasingly incorporating CRP testing to monitor treatment response and adjust interventions in real time, creating an opportunity for testing providers as personalized treatment approaches gain broader adoption.

Emerging Market Trend: AI-Enabled Diagnostics and Automation

Artificial intelligence is enhancing CRP test interpretation by minimizing human error and accelerating result analysis, enabling quicker detection of inflammatory conditions. Integration with electronic health records allows AI to identify patterns and help predict disease progression, while automation reduces manual workload, lowers operational costs, and improves the overall accessibility of CRP testing across care settings.

Market Challenge: Lack of Testing Specificity

A key limitation of CRP testing is that it cannot distinguish the exact cause of inflammation, since elevated levels can result from infections, autoimmune conditions, or a range of chronic diseases. This lack of specificity means CRP results are often used alongside other diagnostic tools rather than as a standalone indicator, which can limit the test's standalone clinical value in certain diagnostic scenarios.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/us-c-reactive-protein-testing-market 

How Is Market Segmentation Done?

The research gives an in-depth segmental analysis of the U.S. C-reactive protein testing industry. The segmentation in the market has been done on the basis of assay type, detection range, disease area, and end use. By assay type, the immuno-turbidimetric assay segment held a major share in 2024 owing to its precision, rapid turnaround, and cost-effectiveness in clinical laboratories, while chemiluminescence immunoassays are expected to grow rapidly given their superior sensitivity for early disease diagnosis. By detection range, hs-CRP is set for robust growth given its critical role in cardiovascular risk assessment. By disease area, cardiovascular diseases held the largest share in 2024, reflecting widespread use of CRP testing to evaluate heart-related inflammation. By end use, hospitals led the market in 2024 as primary centers for diagnosing and managing chronic and acute conditions, while home care settings are expected to grow robustly as portable point-of-care CRP analyzers expand remote patient monitoring options. This analysis helps stakeholders analyze evolving demand trends and recognize promising market opportunities.

Who Are the Key Market Players?

The report presents a detailed competitive analysis of the U.S. C-reactive protein testing industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.

A few of the key players in the market include:

• Abbott Laboratories
• Boditech Med
• Hoffmann-La Roche Ltd
• Getein Biotech
• HORIBA Ltd
• Merck KGaA
• Quest Diagnostics Incorporated
• Randox Laboratories
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.

Future Outlook

The U.S. C-reactive protein testing market is projected to grow and evolve until the forecast year 2034 as demand grows, applications widen, and industry players respond to changing demands. Innovations, investments, and technological advancements are expected to drive market development and present new opportunities in major segments. This report provides insights into how the market is expected to evolve, thereby enabling stakeholders to understand opportunities and developments likely to shape the market during the forecast period.

More Trending Latest Reports By Polaris Market Research:

e-commerce-market

silicon-carbide-market

machine-tools-market

wound-care-market

surfactants-market

gan-gallium-nitride-semiconductor-devices-market

us-biostimulants-market

glioblastoma-multiforme-gbm-treatment-market

industrial-valve-market